POOR ADHERENCE TO TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION IS ASSOCIATED WITH GREATER HEALTH CARE COSTS

被引：0
|
作者：
Baran, R. W. [1 ]
Bhor, M. [1 ]
Laitinen, D. [1 ]
Dietz, B. [2 ]
机构：
[1] Abbott Labs Inc, Abbott Pk, IL USA
[2] Abbott GmbH & Co, Ludwigshafen, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75082-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A421 / A421
页数：1
相关论文
共 50 条
  • [31] Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients
    M. Solomon
    M. Bonafede
    K. Pan
    K. Wilson
    C. Beam
    P. Chakravarti
    B. Spiegel
    Digestive Diseases and Sciences, 2011, 56 : 3024 - 3031
  • [32] Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients
    Solomon, M.
    Bonafede, M.
    Pan, K.
    Wilson, K.
    Beam, C.
    Chakravarti, P.
    Spiegel, B.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (10) : 3024 - 3031
  • [33] MENOPAUSE IS ASSOCIATED WITH RELAPSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Stern, Christiane
    Martinot-Peignoux, Michelle
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Cardoso, Ana Carolina
    El Ray, Ahmed
    Asselah, Tarik
    Valla, Dominique
    Marcellin, Patrick
    HEPATOLOGY, 2010, 52 (04) : 788A - 788A
  • [34] Merimepodib, Pegylated Interferon, and Ribavirin in Genotype 1 Chronic Hepatitis C Pegylated Interferon and Ribavirin Nonresponders
    Rustgi, Vinod K.
    Lee, William M.
    Lawitz, Eric
    Gordon, Stuart C.
    Afdhal, Nezam
    Poordad, Fred
    Bonkovsky, Herbert L.
    Bengtsson, Leif
    Chandorkar, Gurudatt
    Harding, Matthew
    McNair, Lindsay
    Aalyson, Molly
    Alam, John
    Kauffman, Robert
    Gharakhanian, Shahin
    McHutchison, John G.
    HEPATOLOGY, 2009, 50 (06) : 1719 - 1726
  • [35] Prevalence and Impact of Occult Hepatitis B Infection in Chronic Hepatitis C Patients Treated With Pegylated Interferon and Ribavirin
    Levast, Marion
    Larrat, Sylvie
    Thelu, Marie-Ange
    Nicod, Sandrine
    Plages, Agnes
    Cheveau, Alice
    Zarski, Jean-Pierre
    Seigneurin, Jean-Marie
    Morand, Patrice
    Leroy, Vincent
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (05) : 747 - 754
  • [36] Pulmonary hazards of chronic hepatitis C virus infection treatment with Pegylated interferon and ribavirin vs. untreated patients
    Elhelaly, Sanaa
    Elgazzar, Alaa Eldin. M.
    Ragab, Mostafa
    Elkomy, Howida
    Fathy, Talaat
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2013, 62 (02): : 325 - 329
  • [37] Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C
    Condat, Bertrand
    Asselah, Tarik
    Zanditenas, David
    Estampes, Bertrande
    Cohen, Ariel
    O'Toole, Dermot
    Bonnet, Joelle
    Ngo, Yann
    Marcellin, Patrick
    Blazquez, Martine
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (03) : 287 - 289
  • [38] Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
    Mostafa, Hamdy Mahfouz
    Eid, Khaled Abdel Azeem
    Maguid, Mona Mohamed Abdel
    Elsaid, Abdel Rahman Abdel Hamid
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 210 - 210
  • [39] Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'
    Ridruejo, Ezequiel
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (02) : 195 - 195
  • [40] Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in HIV-infected patients
    Romero, M
    Perez-Olmeda, M
    Garcia-Samaniego, J
    Gonzalez, J
    Castro, A
    Arribas, JR
    Pedreira, J
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2002, 36 : 107 - 107
12345